Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

Study overview

This is an open-label, phase II study in patients with resectable and borderline resectable pancreas cancer.

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Medical College of Wisconsin,

Kathleen Christians, MD, PRINCIPAL_INVESTIGATOR, Professor

Study Record Dates

2027-08-01